Selected research
Industry Research
Dutasteride Industry Research Report 2026
Market perspective
The global Dutasteride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dutasteride is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dutasteride is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dutasteride include GSK, Amneal Pharma, Apotex, Bionpharma, Breckenridge Pharmaceutical, Marksans Pharma, Rising Pharmaceuticals, Zydus and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dutasteride market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dutasteride Market by Company
GSK
Amneal Pharma
Apotex
Bionpharma
Breckenridge Pharmaceutical
Marksans Pharma
Rising Pharmaceuticals
Zydus
Mylan
Teva
Dutasteride Segment by Type
Type I
Type II
Dutasteride Segment by Application
Hospital
Drug Store
Dutasteride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dutasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dutasteride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dutasteride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dutasteride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Type I
- Type II
Applications
- Hospital
- Drug Store
Companies covered
- GSK
- Amneal Pharma
- Apotex
- Bionpharma
- Breckenridge Pharmaceutical
- Marksans Pharma
- Rising Pharmaceuticals
- Zydus
- Mylan
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dutasteride Market Size (2021-2032)
- 2.2.2 Global Dutasteride Sales (2021-2032)
- 2.2.3 Global Dutasteride Market Average Price (2021-2032)
- 2.3 Dutasteride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Type I
- 2.3.3 Type II
- 2.4 Dutasteride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dutasteride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dutasteride Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Dutasteride Revenue of Manufacturers (2021-2026)
- 3.4 Global Dutasteride Average Price by Manufacturers (2021-2026)
- 3.5 Global Dutasteride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dutasteride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dutasteride, Product Type & Application
- 3.8 Global Manufacturers of Dutasteride, Established Date
- 3.9 Global Dutasteride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Dutasteride Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Amneal Pharma
- 4.2.1 Amneal Pharma Company Information
- 4.2.2 Amneal Pharma Business Overview
- 4.2.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Pharma Dutasteride Product Portfolio
- 4.2.5 Amneal Pharma Recent Developments
- 4.3 Apotex
- 4.3.1 Apotex Company Information
- 4.3.2 Apotex Business Overview
- 4.3.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Apotex Dutasteride Product Portfolio
- 4.3.5 Apotex Recent Developments
- 4.4 Bionpharma
- 4.4.1 Bionpharma Company Information
- 4.4.2 Bionpharma Business Overview
- 4.4.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bionpharma Dutasteride Product Portfolio
- 4.4.5 Bionpharma Recent Developments
- 4.5 Breckenridge Pharmaceutical
- 4.5.1 Breckenridge Pharmaceutical Company Information
- 4.5.2 Breckenridge Pharmaceutical Business Overview
- 4.5.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
- 4.5.5 Breckenridge Pharmaceutical Recent Developments
- 4.6 Marksans Pharma
- 4.6.1 Marksans Pharma Company Information
- 4.6.2 Marksans Pharma Business Overview
- 4.6.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Marksans Pharma Dutasteride Product Portfolio
- 4.6.5 Marksans Pharma Recent Developments
- 4.7 Rising Pharmaceuticals
- 4.7.1 Rising Pharmaceuticals Company Information
- 4.7.2 Rising Pharmaceuticals Business Overview
- 4.7.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rising Pharmaceuticals Dutasteride Product Portfolio
- 4.7.5 Rising Pharmaceuticals Recent Developments
- 4.8 Zydus
- 4.8.1 Zydus Company Information
- 4.8.2 Zydus Business Overview
- 4.8.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zydus Dutasteride Product Portfolio
- 4.8.5 Zydus Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Dutasteride Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 Teva
- 4.10.1 Teva Company Information
- 4.10.2 Teva Business Overview
- 4.10.3 Teva Dutasteride Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Dutasteride Product Portfolio
- 4.10.5 Teva Recent Developments
5 Global Dutasteride Market Scenario by Region
- 5.1 Global Dutasteride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dutasteride Sales by Region: 2021-2032
- 5.2.1 Global Dutasteride Sales by Region: 2021-2026
- 5.2.2 Global Dutasteride Sales by Region: 2027-2032
- 5.3 Global Dutasteride Revenue by Region: 2021-2032
- 5.3.1 Global Dutasteride Revenue by Region: 2021-2026
- 5.3.2 Global Dutasteride Revenue by Region: 2027-2032
- 5.4 North America Dutasteride Market Facts & Figures by Country
- 5.4.1 North America Dutasteride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dutasteride Sales by Country (2021-2032)
- 5.4.3 North America Dutasteride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Dutasteride Market Facts & Figures by Country
- 5.5.1 Europe Dutasteride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dutasteride Sales by Country (2021-2032)
- 5.5.3 Europe Dutasteride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Dutasteride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dutasteride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dutasteride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dutasteride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dutasteride Market Facts & Figures by Country
- 5.7.1 South America Dutasteride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dutasteride Sales by Country (2021-2032)
- 5.7.3 South America Dutasteride Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Dutasteride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dutasteride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dutasteride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dutasteride Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Dutasteride Sales by Type (2021-2032)
- 6.1.1 Global Dutasteride Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Dutasteride Sales Market Share by Type (2021-2032)
- 6.2 Global Dutasteride Revenue by Type (2021-2032)
- 6.2.1 Global Dutasteride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dutasteride Revenue Market Share by Type (2021-2032)
- 6.3 Global Dutasteride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dutasteride Sales by Application (2021-2032)
- 7.1.1 Global Dutasteride Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Dutasteride Sales Market Share by Application (2021-2032)
- 7.2 Global Dutasteride Revenue by Application (2021-2032)
- 7.2.1 Global Dutasteride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dutasteride Revenue Market Share by Application (2021-2032)
- 7.3 Global Dutasteride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dutasteride Value Chain Analysis
- 8.1.1 Dutasteride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dutasteride Production Mode & Process
- 8.2 Dutasteride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dutasteride Distributors
- 8.2.3 Dutasteride Customers
9 Global Dutasteride Analyzing Market Dynamics
- 9.1 Dutasteride Industry Trends
- 9.2 Dutasteride Industry Drivers
- 9.3 Dutasteride Industry Opportunities and Challenges
- 9.4 Dutasteride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst